News
Important Only
Eupraxia Doses First Patient In Phase 2B Placebo-Controlled Portion Of Ep-104GI Resolve Trial
July 8 (Reuters) - Eupraxia Pharmaceuticals Inc EPRX.TO:EUPRAXIA DOSES FIRST PATIENT IN PHASE 2B PLACEBO-CONTROLLED PORTION OF EP-104GI RESOLVE TRIAL IN EOSINOPHILIC ESOPHAGITISEUPRAXIA PHARMACEUTICALS INC - TOPLINE DATA FROM PHASE 2B STUDY EXPECTED BY Q3 2026Reuters
Tue, Jul 8
Morning News Call - U.S., July 8
To access a PDF version of this newsletter, please click here You can read Morning News Call -- US via TOPNEWS U.S. Companies page.If you would like to receive this newsletter through your email, please register at:https://solutions.lseg.com/MorningNewsCallEN-subscription-page For Morning Ne...Reuters
Tue, Jul 8
Upstream Bio Announces First Patient Dosed In Phase 2 Clinical Trial Of Verekitug
July 8 (Reuters) - Upstream Bio Inc UPB.O:UPSTREAM BIO ANNOUNCES FIRST PATIENT DOSED IN PHASE 2 CLINICAL TRIAL OF VEREKITUG IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)UPSTREAM BIO INC - DOSES FIRST PATIENT IN PHASE 2 COPD TRIALReuters
Tue, Jul 8
Prokidney Reports Statistically And Clinically Significant Topline Results For The Phase 2 REGEN-007 Trial
July 8 (Reuters) - ProKidney Corp PROK.O:PROKIDNEY REPORTS STATISTICALLY AND CLINICALLY SIGNIFICANT TOPLINE RESULTS FOR THE PHASE 2 REGEN-007 TRIAL EVALUATING RILPARENCEL IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND DIABETESPROKIDNEY CORP - NO SERIOUS ADVERSE EVENTS OBSERVED WITH RILPARENCEL TREATMEN...Reuters
Tue, Jul 8
Adagene Inc - Partners With Conjugatebio For Antibody Drug Conjugate Development
July 8 (Reuters) - Adagene Inc 978y.F:ADAGENE INC - PARTNERS WITH CONJUGATEBIO FOR ANTIBODY DRUG CONJUGATE DEVELOPMENTADAGENE INC - TO RECEIVE UNDISCLOSED UPFRONT AND ROYALTY PAYMENTSADAGENE INC - RETAINS NON-ADC RIGHTS TO PARTNERED ANTIBODYFurther company coverage: [978y.F]Reuters
Tue, Jul 8
Eton Pharmaceuticals Announces FDA Acceptance Of New Drug Application For Et-600
July 8 (Reuters) - Eton Pharmaceuticals Inc ETON.O:ETON PHARMACEUTICALS ANNOUNCES FDA ACCEPTANCE OF NEW DRUG APPLICATION FOR ET-600 (DESMOPRESSIN ORAL SOLUTION)ETON PHARMACEUTICALS INC - NDA TARGET ACTION DATE SET FOR FEBRUARY 25, 2026ETON PHARMACEUTICALS INC - ET-600 HAS PATENT PROTECTION THROUGH 2...Reuters
Tue, Jul 8
Fulcrum Metals Extends LOI Closing Date For Tully Gold Sale To 30 Sept
July 8 (Reuters) - Fulcrum Metals PLC FMETF.L:FULCRUM METALS PLC - EXTENSION OF LOI FOR THE SALE OF TULLY GOLDFULCRUM METALS PLC - EXTENDS LOI WITH LOYALIST FOR TULLY GOLD PROJECT SALEFULCRUM METALS PLC: CLOSING DATE ON LOI EXTENDED TO NO LATER THAN 30 SEPTReuters
Tue, Jul 8
Richelieu Hardware Ltd expected to post earnings of 43 cents a share - Earnings Preview
Richelieu Hardware Ltd RCH.TO is expected to show a rise in quarterly revenue when it reports results on July 10 for the period ending May 31 2025The Saint-laurent Quebec-based company is expected to report a 7.2% increase in revenue to C$516.2 million from C$481.43 million a year ago, according ...Reuters
Tue, Jul 8
Lexaria Bioscience Corp expected to post a loss of 16 cents a share - Earnings Preview
Lexaria Bioscience Corp LEXX.OQ LEXX.O is expected to show a rise in quarterly revenue when it reports results on July 10 (estimated) for the period ending May 31 2025The Kelowna British Columbia-based company is expected to report a 8.7% increase in revenue to $91.33 thousand from $84 thousand a ...Reuters
Tue, Jul 8
No compelling evidence for EU veto of ETraveli, Booking tells court
By Foo Yun Chee LUXEMBOURG, July 8 (Reuters) - Booking Holdings BKNG.O on Tuesday criticised an EU antitrust veto over its 1.63-billion-euro ($1.9 billion) ETraveli deal almost two years ago, saying regulators failed to provide clear, compelling evidence to show anti-competitive harm.The U.S. onl...Reuters
Tue, Jul 8
Structural reforms are needed for German rebound, economy minister says
BERLIN, July 8 (Reuters) - Structural reforms are a requirement for the German economy to grow again, German Economy Minister Katherina Reiche said on Tuesday in the lower house of parliament.German business associations have criticised the new government's surge in public spending which targets...Reuters
Tue, Jul 8
Private investment platform Linqto files for bankruptcy amid SEC scrutiny
July 8 (Reuters) - Linqto, the investment platform that allows users access to shares of privately held companies, filed for bankruptcy on Tuesday, citing challenges stemming from alleged securities law violations.The company is under investigation by the Securities and Exchange Commission and other...Reuters
Tue, Jul 8
